Furthermore, recent investigations employing microarray technologies have consistently identified COL11A1 overexpression in several cancer types (such as breast cancer, lung adenocarcinoma, and hypopharyngeal cancer) versus their corresponding normal tissues [30–32]. This evidence concerns the gene COL11A1 and hypopharynx cancer.